Alkermes PLC | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
145.83 M |
Public Float |
- |
Alkermes PLC | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.11 |
Market Cap |
$3.56 B |
Shares Outstanding |
156.9 M |
Public Float |
154.27 M |
Address |
Connaught House Dublin Dublin D04 C5Y6 Ireland |
Employees | - |
Website | http://www.alkermes.com |
Updated | 07/08/2019 |
Alkermes Plc IS a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. It operates through the following geographical segments: U. S. |